When one thousand Web sites produced by some of the world’s foremost pharmaceutical companies - AstraZeneca, Eli Lilly, GlaxosmithKline, Janssen, Merck/MSD, Novartis, Pfizer, Roche and Sanofi-Aventis – were catalogued and analysed across five geographic zones, one of the key facts that emerged was the predominance of the diabetes as the focus of satellite sites, over other major therapeutic areas.
The multi-criteria grids developed by LexisNexis Analytics make it possible to also identify, within each therapeutic area, the most innovative and differentiating online tools used by the laboratories in order to communicate with their various audiences (patients, healthcare professionals, etc.), which they base on traditional Web, mobile Web or social media.
Aucun commentaire:
Enregistrer un commentaire